Navigation Links
Hahnemann University Hospital Receives Approval From The Commission on Cancer
Date:4/3/2009

PHILADELPHIA, April 3 /PRNewswire-USNewswire/ -- The Cancer Center at Hahnemann University Hospital has been granted a Three-Year Approval with Commendation by The Commission on Cancer (CoC) of the American College of Surgeons (ACoS).

The Cancer Center at Hahnemann received the approval following an on-site evaluation by a physician surveyor. Approval by the CoC is awarded only to those facilities that have voluntarily committed to providing the highest level of quality cancer care and that undergo a rigorous evaluation process and review of their performance. Receiving care at a CoC-approved cancer program ensures that a patient will have access to:

  • Comprehensive care, including a range of state-of-the-art services and equipment
  • A multispecialty, team approach to coordinate the best treatment options
  • Information about ongoing clinical trials and new treatment options
  • Access to cancer-related information, education, and support
  • A cancer registry that collects data on type and stage of cancers and treatment results and offers lifelong patient follow-up
  • Ongoing monitoring and improvement of care
  • Quality care close to home

"The Cancer Center at Hahnemann provides high quality care by taking a unique multidisciplinary approach. The Cancer Center offers a wide range of services to help patients both physically and emotionally over their course of treatment," stated Michael P. Halter, FACHE, chief executive officer of Hahnemann University Hospital.

Approximately 25 percent of hospitals in America and Puerto Rico that treat cancer patients have received the approval award from the Commission on Cancer. Despite only representing a quarter of hospitals nationwide, CoC-accredited hospitals diagnose and/or treat 80 percent of newly diagnosed cancer patients each year.

About Hahnemann University Hospital

Hahnemann University Hospital is a 541-bed academic medical center at Broad and Vine Streets in Philadelphia, Pa. The hospital is a tertiary care institution that specializes in cardiac services, heart failure and transplantation, OB/GYN, orthopedics, medical, surgical and radiation oncology, bone marrow transplantation, renal dialysis and kidney/pancreas/liver transplantation. Hahnemann is recognized by the American Heart Association as a leader in coronary artery disease and heart failure treatments. The hospital performed one of the city's first kidney transplants in 1963 and one of the first bone marrow transplants in 1976. Hahnemann became Philadelphia's first Level I Regional Resource Trauma Center for adults in 1986, and since then has been served by MidAtlantic MedEvac, an aeromedical transport program for critically ill patients. Hahnemann is proud to be the first hospital in Philadelphia to join with The Wellness Community of Philadelphia to offer onsite support and education services to cancer patients and their families. Hahnemann is fully accredited by the Joint Commission on the Accreditation of Healthcare Organizations, the nation's oldest and largest hospital accreditation agency. An affiliate of Drexel University College of Medicine, Hahnemann University Hospital is part of Tenet Pennsylvania, which also includes St. Christopher's Hospital for Children. To learn more about Hahnemann, visit www.hahnemannhospital.com


'/>"/>
SOURCE Hahnemann University Hospital
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Hahnemann University Hospital and St. Christophers Hospital for Children Receive Prestigious Tenet Circle of Excellence Award
2. Hahnemann University Hospital and St. Christophers Hospital for Children Extend Current Agreement With Independence Blue Cross
3. Hospital Workers Ratify Contract With Hahnemann
4. University of Iowa professor identifies new eating disorder
5. University of Wisconsin Hospitals and Clinics Complete System-Wide Conversion to Masimo SET Pulse Oximetry Technology
6. University of Texas Study Details Lengthy Payment Delays for Medicare Part D Prescription Drug Claims, Confirming Need for Legislative Fix
7. Tulane University to receive $14M for international HIV/AIDS program
8. University of Nevada School of Medicine Professor Confirms Accuracy Through Validation Study Using the CSI Health Station Model 6K
9. Boston University School of Medicine researcher recipient of Memory Ride Grant
10. Loma Linda University Medical Center Selects Beryl to Manage Call Center Interactions for Womens Services Programs and Departments
11. Medina General Hospital and University Hospitals Agree to Pursue Affiliation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from PsychTests.com reveals that behind the tendency to set ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are recognized ... this recognition are considered among the top 2 percent of lawyers practicing within the ... this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, Burt ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... is proud to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon ... beautiful women in the world, and the most handsome men, look naturally attractive. ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... p.m. (Eastern Daylight Time). As previously announced ... into a definitive merger agreement under which Jazz Pharmaceuticals ...
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... June 24, 2016 Dehaier Medical Systems Ltd. ... which develops, markets and sells medical devices and wearable ... signed a strategic cooperation agreement with Hongyuan Supply Chain ... Chain") on June 20, 2016, to develop Dehaier,s new ... cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s sales ...
Breaking Medicine Technology: